Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02042495
Title Endometrial Cancer Biomarker Changes Following Exposure to Metformin
Recruitment Withdrawn
Gender female
Phase Phase II
Variant Requirements No
Sponsors Jewish General Hospital
Indications

endometrial cancer

Therapies

Metformin

Age Groups: adult | senior
Covered Countries CAN


No variant requirements are available.